Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Prospective high-throughput genome profiling by comparative genomic hybridization (CGH) in advanced cancers.

ABSTRACT: We conducted a prospective monocenter clinical trial called PERMED01 to evaluate the number patients with locally advanced or metastatic cancer for whom identification of molecular alterations in tumor samples could lead to the delivery of a targeted therapy. Patients accessible to tumor biopsy were prospectively enrolled at the Paoli-Calmettes Institute in the PERMED01 study (ClinicalTrials.gov, NCT02342158). Genomic profiling of frozen tissue was established by whole-genome array comparative genomic hybridization (aCGH)

ORGANISM(S): Homo sapiens

SUBMITTER: Arnaud Guille

PROVIDER: E-MTAB-9998 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Investigation of molecular features involved in clinical responses and survival in advanced endometrial carcinoma

Project description:Hormone therapy (HT) is an effective treatment for metastatic endometrial carcinoma (mEC), with limited toxicity and low cost. We focused on molecular analysis of mECs treated by HT and, for the first time to date, we compared genomic profiles of paired metastasis and primary ECs. The main objective was to identify predictive factors of response to HT as well as specific altered signalling pathways driving mEC biology. We evaluated gene alterations by array-based comparative genomic hybridization

2022-03-16 | E-MTAB-11552 | biostudies-arrayexpress

CGH-array of breast cancer and paired brain metastases

Project description:We performed a differential analysis of copy-number-alterations (CNAs) and mutations profiles by using pan-genomic array-CGH and next-generation-sequencing of 365 ‘cancer-associated’ genes, in a series of 14 pairs of matched primary breast cancer (PBC)/brain metastasis (BM) and assessed if the observed genomic alterations may be used as a druggable agent in a clinical trial.

2020-08-02 | E-MTAB-7118 | biostudies-arrayexpress

Genome profiling by comparative genomic hybridization (CGH) in pediatric osteosarcoma

Project description:In some types of cancer, telomere length is maintained by the Alternative Lengthening of Telomeres (ALT) mechanism. We characterized a series of high-grade osteosarcomas from 22 non-metastatic and non-pre-treated pediatric patients. Using the presence of circular partially single-stranded extrachromosomal C-rich telomeric repeat sequences (C-Circles) as an ALT marker, we found that 16 of the 22 high-grade osteosarcomas were ALT-positive. In order to find copy number alterations associated with ALT mechanims, we used comparative genomic hybridization (CGH).

2022-05-13 | E-MTAB-11747 | biostudies-arrayexpress

Cholesterol pathway influences tumor molecular differentiation and impacts survival in colon cancer patients

Project description:Part of a meta-analysis, DNA microarrays were used to define the transcriptional profiles of tumor samples of 50 colon cancer samples at Institut Paoli-Calmettes.

2022-09-01 | E-MTAB-11754 | biostudies-arrayexpress

Inflammatory Breast Cancer

Project description:Gene expression profiles were established for Inflammatory breast cancer samples from patients treated at the Institut Paoli-Calmettes.

2014-01-13 | E-MTAB-1547 | biostudies-arrayexpress

Comparative genomic hybridization (CGH) of human breast cancer cell line SUM190 treated with Nectin4 ADC

Project description:Nectin-4 is a new therapeutic target in various carcinomas. We were interested in resistance to anti-nectin 4 ADC in breast cancer and the way to overcome it. Tumor DNA were extracted from sensitive and resistant pre-clinical models. Genomic profiles of samples were established by using array-CGH onto 4×180K CGH microarrays.

2022-05-01 | E-MTAB-11681 | biostudies-arrayexpress

PRCC_CGH

Project description:Papillary renal cell carcinomas (pRCC) are the second most common form of renal carcinoma, after clear cell Renal carcinoma (ccRCC). PRCC account for 10 to 15% of RCC and gather a heterogeneous population with no specific systemic treatment. Pathological classification by Elbe divides pRCC population in two morphologically different subtypes. Type 1 consists of predominantly basophilic cells, whereas type 2 contains mostly eosinophilic cells. Type 1 architecture corresponds with a single line of cells along the papillary axis, whereas type 2 generally exhibits several cell strata on the axis. Furthermore, type 2 cells demonstrate more aggressive characteristics, such as the presence of nucleoli and increased nuclear size. The papillary cores often contain edema fluid, foamy macrophages, and psammoma bodies. Further clinical reports identified that type I tumors are more likely to present as numerous, bilateral , indolent, low grade pRCC, whereas type II are associated with higher grade and poor prognosis related to metastatic evolution. The goal of this study wad to characterize each sample in order to get an idea of the genomic profile in pRCC type 2 (pRCCII).

2014-07-22 | E-MTAB-1807 | biostudies-arrayexpress

Comparative genomic hybridization (CGH) in glioblastomas

Project description:Ten pairs frozen Glioblastoma Multiforme (GBM) from initial and recurrent surgery after radio-chemotherapy were screened by CGH Array.

2021-03-01 | E-MTAB-10079 | biostudies-arrayexpress

NPMâ??ALK permits the survival of thymic T cells with aberrant T cell receptor rearrangements enabling thymic escape and tumor development

Project description:We present evidence to support a new model of Anaplastic Large Cell Lymphoma (ALCL) pathogenesis in which the malignancy is initiated in early thymocytes, prior to TCR rearrangement which is bypassed in NPMâ??ALK transgenic mice following Notch1 expression. In support, we show that T cell receptor (TCR) rearrangements are aberrant in some human ALCL, yielding events that would not normally be permissive for survival during T cell development. However, a TCR is required for thymic egress and subsequent development of peripheral tumors in mice yet this TCR must be downâ??regulated for Tâ??cell lymphomagenesis. Children affected by ALCL may thus harbor lymphoma-initiating cells in the thymocyte population that seeds relapse after chemotherapy. comparative genomic hybridization data from 43 human Anaplastic Large Cell Lymphoma (ALCL) samples and control samples

2016-01-05 | E-GEOD-67131 | biostudies-arrayexpress

APC colon stage II

Project description:Analysis of expression profiles in stage II colon cancer according to the APC gene status retrospective study

2011-01-28 | E-GEOD-26906 | biostudies-arrayexpress